![Clinical characteristics and genotypes in the ADVANCE baseline data set, a comprehensive cohort of US children and adolescents with Pompe disease | Genetics in Medicine Clinical characteristics and genotypes in the ADVANCE baseline data set, a comprehensive cohort of US children and adolescents with Pompe disease | Genetics in Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41436-019-0527-9/MediaObjects/41436_2019_527_Fig1_HTML.png)
Clinical characteristics and genotypes in the ADVANCE baseline data set, a comprehensive cohort of US children and adolescents with Pompe disease | Genetics in Medicine
![IJNS | Free Full-Text | Is Newborn Screening the Ultimate Strategy to Reduce Diagnostic Delays in Pompe Disease? The Parent and Patient Perspective IJNS | Free Full-Text | Is Newborn Screening the Ultimate Strategy to Reduce Diagnostic Delays in Pompe Disease? The Parent and Patient Perspective](https://www.mdpi.com/IJNS/IJNS-06-00001/article_deploy/html/images/IJNS-06-00001-g001.png)
IJNS | Free Full-Text | Is Newborn Screening the Ultimate Strategy to Reduce Diagnostic Delays in Pompe Disease? The Parent and Patient Perspective
![Development of facial muscle weakness over time in four patients with... | Download Scientific Diagram Development of facial muscle weakness over time in four patients with... | Download Scientific Diagram](https://www.researchgate.net/publication/51726773/figure/fig3/AS:667060816322561@1536051100047/Development-of-facial-muscle-weakness-over-time-in-four-patients-with-classic-infantile.jpg)
Development of facial muscle weakness over time in four patients with... | Download Scientific Diagram
![Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy | Orphanet Journal of Rare Diseases | Full Text Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy | Orphanet Journal of Rare Diseases | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1750-1172-6-34/MediaObjects/13023_2011_Article_303_Fig3_HTML.jpg)
Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy | Orphanet Journal of Rare Diseases | Full Text
Pompe Disease Treatment Market Strategy, Emerging Technologies, Global Trends and Forecast by Regions
![Carrier frequency and predicted genetic prevalence of Pompe disease based on a general population database - ScienceDirect Carrier frequency and predicted genetic prevalence of Pompe disease based on a general population database - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2214426921000288-gr3.jpg)
Carrier frequency and predicted genetic prevalence of Pompe disease based on a general population database - ScienceDirect
![She wasn't expected to be alive at 12 but girl with rare Pompe disease thrives on parents' love - TODAY She wasn't expected to be alive at 12 but girl with rare Pompe disease thrives on parents' love - TODAY](https://onecms-res.cloudinary.com/image/upload/s--kJUkLI9b--/c_fill,g_auto,h_676,w_1200/f_auto,q_auto/v1/tdy-migration/20210414_raj_pompe_disease2.jpg?itok=ehLBFbq_)
She wasn't expected to be alive at 12 but girl with rare Pompe disease thrives on parents' love - TODAY
![Biomolecules | Free Full-Text | Pompe Disease: New Developments in an Old Lysosomal Storage Disorder Biomolecules | Free Full-Text | Pompe Disease: New Developments in an Old Lysosomal Storage Disorder](https://www.mdpi.com/biomolecules/biomolecules-10-01339/article_deploy/html/images/biomolecules-10-01339-g001.png)
Biomolecules | Free Full-Text | Pompe Disease: New Developments in an Old Lysosomal Storage Disorder
![Effect of alglucosidase alfa dosage on survival and walking ability in patients with classic infantile Pompe disease: a multicentre observational cohort study from the European Pompe Consortium - The Lancet Child & Effect of alglucosidase alfa dosage on survival and walking ability in patients with classic infantile Pompe disease: a multicentre observational cohort study from the European Pompe Consortium - The Lancet Child &](https://www.thelancet.com/cms/attachment/4eccf0b5-b460-4566-946d-79c3235032a0/gr1_lrg.jpg)
Effect of alglucosidase alfa dosage on survival and walking ability in patients with classic infantile Pompe disease: a multicentre observational cohort study from the European Pompe Consortium - The Lancet Child &
![Frontiers | Case Report: Anesthetic Management and Electrical Cardiometry as Intensive Hemodynamic Monitoring During Cheiloplasty in an Infant With Enzyme-Replaced Pompe Disease and Preserved Preoperative Cardiac Function Frontiers | Case Report: Anesthetic Management and Electrical Cardiometry as Intensive Hemodynamic Monitoring During Cheiloplasty in an Infant With Enzyme-Replaced Pompe Disease and Preserved Preoperative Cardiac Function](https://www.frontiersin.org/files/Articles/729824/fped-09-729824-HTML-r1/image_m/fped-09-729824-g001.jpg)
Frontiers | Case Report: Anesthetic Management and Electrical Cardiometry as Intensive Hemodynamic Monitoring During Cheiloplasty in an Infant With Enzyme-Replaced Pompe Disease and Preserved Preoperative Cardiac Function
![Orofacial features and pediatric dentistry in the long-term management of Infantile Pompe Disease children | Orphanet Journal of Rare Diseases | Full Text Orofacial features and pediatric dentistry in the long-term management of Infantile Pompe Disease children | Orphanet Journal of Rare Diseases | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13023-020-01615-1/MediaObjects/13023_2020_1615_Fig1_HTML.jpg)